FDA May Support Incentives For Electronic Submissions In Next User Fee Act
Executive Summary
FDA is considering using incentives to promote electronic submissions in the next version of the Prescription Drug User Fee Act
You may also be interested in...
FDA Dedicating 30% Of Leftover User Fees To White Oak Move
FDA has reserved nearly 30% of its unused user fees for fiscal year 2004 for the agency's upcoming move to a new facility in White Oak, Md., the FY 2004 Prescription Drug User Fee Financial Report states
FDA Dedicating 30% Of Leftover User Fees To White Oak Move
FDA has reserved nearly 30% of its unused user fees for fiscal year 2004 for the agency's upcoming move to a new facility in White Oak, Md., the FY 2004 Prescription Drug User Fee Financial Report states
IoM Drug Safety Study May Buy Time For FDA; Report Will Play In PDUFA IV
FDA's decision to proceed with an Institute of Medicine review of drug safety regulation could trigger a full-fledged debate over the possibility of creating a separate post-marketing regulatory agency in the U.S